1
-
2
of
2
results (0.53 seconds)
Sort By:
-
Session 015: Actuaries and Pharmaceutical Manufacturers: Friend or Foe?
Session 015: Actuaries and Pharmaceutical Manufacturers: Friend or Foe? Recently, actuaries ... create a mutual understanding that will begin to direct future conversations to benefit both stakeholders ...- Authors: Whitney Pratt, Jason Fehr, Karl J. Gregor
- Date: May 2019
- Competency: Strategic Insight and Integration
- Topics: Actuarial Profession>Professional development; Economics>Health economics
-
Session 133: Leveraging Real-World Data to Enhance Existing Actuarial Analytics and to Potentially Evolve Actuarial Methods and Value Drivers
Evolve Actuarial Methods and Value Drivers Health care is a complex market with a wide variety of stakeholders ... treatment, clinical outcomes, and costs of health care in real treatment settings (e.g.,, outside of controlled ...- Authors: James Dolstad, Karl J. Gregor, Andrew Mackenzie, David L. Van Brunt
- Date: May 2019
- Competency: External Forces & Industry Knowledge
- Topics: Economics>Health economics; Health & Disability>Health insurance